JPRN-UMIN000006761招募中未知
Efficacy of interferon therapy for recurrence-free and overall survival after curative radiofrequency ablation for HCV-related hepatocellular carcinoma. - IFN Therapy after RFA for HCC
Kyoundo hospital0 个研究点目标入组 50 人开始时间: 2011年11月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)uncontrollable heart disease 2)extrahepatic metastasis of hepatocellular carcinoma 3)another active cancer 4)chronic renal failure 5)taking Shosai-Koto(Chinese medicine) 6)autoimmune and other viral hepatitis 7)depression and psychiatric disease 8)pregnancy and during lactation
研究者
相似试验
招募中
不适用
Efficacy and safety of interferon-free treatment in patients with chronic hepatitis Cchronic hepatitis CJPRN-UMIN000037575Osaka university1,000
招募中
不适用
The long-term follow-up interferon-a treatment for chronic hepatitis B infectioChronic hepatitis B infection10019654NL-OMON43380Stichting Leveronderzoek40
招募中
不适用
Analysis of efficacy and safety of interferon-free therapy for recurrent hepatitis C after liver transplantatiohepatitis C after liver transplantationJPRN-UMIN000018759Kyoto University Hospital50
进行中（未招募）
1 期
The purpose of this study is to evaluate how effective, safe and tolerable Sofosbuvir (SOF)/Velpatasvir(VEL) is when taken by people with recent hepatitis C virus (HCV) infection, in particular whether the length of treatment can be shortened. Study participants will be randomly (occur by chance) assigned into one of the two different groups. The short treatment duration group will receive SOF/VEL for 6 weeks and the standard treatment duration group will receive SOF/VEL for 12 weeks.Recent hepatitis C virus infection all genotypes.MedDRA version: 20.0Level: PTClassification code 10019744Term: Hepatitis CSystem Organ Class: 10021881 - Infections and infestationsEUCTR2015-004243-39-NLniversity of New South Wales Australia250
进行中（未招募）
1 期
A study to evaluate how effective, safe and tolerable Sofosbuvir/Velpatasvir is when taken by people with recent hepatitis C virus infection, in particular whether the length of treatment can be shortened.Recent hepatitis C virus infection all genotypes.MedDRA version: 20.0Level: PTClassification code 10019744Term: Hepatitis CSystem Organ Class: 10021881 - Infections and infestationsEUCTR2015-004243-39-GBThe University of New South Wales Australia250